Sökning: onr:"swepub:oai:DiVA.org:uu-383502" >
Rhabdomyosarcoma di...
Rhabdomyosarcoma diagnosed in the first year of life : Localized, metastatic, and relapsed disease. Outcome data from five trials and one registry of the Cooperative Weichteilsarkom Studiengruppe (CWS)
-
- Sparber-Sauer, Monika (författare)
- Klinikum Stuttgart Olgahosp, Stuttgart Canc Ctr, Zentrum Kinder Jugend & Frauenmed, Pediat Oncol Hematol Immunol 5, Stuttgart, Germany
-
- Stegrnaier, Sabine (författare)
- Klinikum Stuttgart Olgahosp, Stuttgart Canc Ctr, Zentrum Kinder Jugend & Frauenmed, Pediat Oncol Hematol Immunol 5, Stuttgart, Germany
-
- Vokuhl, Christian (författare)
- Kiel Pediat Tumor Registry, Dept Pathol, Sect Pediat Pathol, Kiel, Germany
-
visa fler...
-
- Seitz, Guido (författare)
- Univ Childrens Hosp Marburg, Dept Pediat Surg, Marburg, Germany
-
- von Kalle, Thekla (författare)
- Olga Hosp, Stuttgart Canc Ctr, Zentrum Kinder Jugend & Frauenmed, Klinikum Stuttgart,Inst Radiol, Stuttgart, Germany
-
- Scheer, Monika (författare)
- Klinikum Stuttgart Olgahosp, Stuttgart Canc Ctr, Zentrum Kinder Jugend & Frauenmed, Pediat Oncol Hematol Immunol 5, Stuttgart, Germany
-
- Muenter, Marc (författare)
- Klinikum Stuttgart, Inst Radiotherapy, Stuttgart, Germany
-
- Bielack, Stefan S. (författare)
- Klinikum Stuttgart Olgahosp, Stuttgart Canc Ctr, Zentrum Kinder Jugend & Frauenmed, Pediat Oncol Hematol Immunol 5, Stuttgart, Germany;Univ Munster, Dept Pediat Hematol & Oncol, Munster, Germany
-
- Weclawek-Tompol, Jadwiga (författare)
- Univ Wroclaw, Dept Pediat Hematol Oncol & BMT, Wroclaw, Poland
-
- Ladenstein, Ruth (författare)
- St Anna Childrens Hosp, Pediat Oncol, Vienna, Austria
-
- Niggli, Felix (författare)
- Univ Zurich, Dept Pediat Oncol, Zurich, Switzerland
-
- Ljungman, Gustaf, 1958- (författare)
- Uppsala universitet,Barnneurologi/Barnonkologi
-
- Fuchs, Joerg (författare)
- Univ Childrens Hosp, Dept Pediat Surg & Urol, Tubingen, Germany
-
- Hettmer, Simone (författare)
- Univ Freiburg, Fac Med, Dept Pediat & Adolescent Med, Div Pediat Hematol & Oncol, Freiburg, Germany
-
- Koscielniak, Ewa (författare)
- Klinikum Stuttgart Olgahosp, Stuttgart Canc Ctr, Zentrum Kinder Jugend & Frauenmed, Pediat Oncol Hematol Immunol 5, Stuttgart, Germany;Childrens Hosp, Dept Pediat Hematol & Oncol, Tubingen, Germany
-
- Klingebiel, Thomas (författare)
- Univ Hosp Frankfurt, Dept Children & Adolescents, Frankfurt, Germany
-
visa färre...
-
(creator_code:org_t)
- 2019-02-14
- 2019
- Engelska.
-
Ingår i: Pediatric Blood & Cancer. - : Wiley. - 1545-5009 .- 1545-5017. ; 66:6
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background Rhabdomyosarcoma (RMS) diagnosed during the first year of life is reported to have poor outcome. Little is known about treatment and outcome data of relapsed disease (RD).MethodsCharacteristics, treatment, and outcome of 155 patients <= 12 months registered within the Cooperative Weichteilsarkom Studiengruppe (CWS) between 1981 and 2016 were evaluated.Results Localized disease (LD) was diagnosed in 144 patients and metastatic disease (MD) in 11. The histological diagnosis was alveolar (RMA) (n = 38, 23/25 examined patients PAX7/3:FOXO1-positive), embryonal (RME) (n = 100), botryoid (n = 10), anaplastic (n = 1), and spindle-cell RMS (n = 6). Multimodal treatment including conventional (age-adjusted) chemotherapy (CHT) (n = 150), resection (n = 137), and radiotherapy (RT) (n = 37) was administered. Complete remission was achieved in 129 of 144 patients with LD. RD occurred in 51 infants at a median age of 1.7 years (range, 0.3-8.8). Sixty-three percent of patients with RMA suffered RD, in contrast to 28% of patients with RME. Relapse treatment consisted of conventional CHT (n = 48), resection (n = 28), and RT (n = 21). The pattern of relapse and best resection were significant prognostic factors for patients with RD (P = 0.000 and P = 0.002). Late effects occurred as secondary malignancies in 6%, long-term toxicity in 21%, and resection-related impairment in 33% of the 105 surviving patients. The 5-year event-free survival and overall survival for infants with initial LD were 51% and 69%, 14% and 14% for patients with initial MD and 39% and 41% for relapsed patients, respectively.Conclusion Multimodal treatment including microscopically complete resection is strongly recommended to achieve a good prognosis in LD and RD of infants with RMS.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Hematologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Hematology (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Pediatrik (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Pediatrics (hsv//eng)
Nyckelord
- CWS Group
- infants
- localized disease
- metastatic disease
- relapsed disease
- rhabdomyosarcoma
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Sparber-Sauer, M ...
-
Stegrnaier, Sabi ...
-
Vokuhl, Christia ...
-
Seitz, Guido
-
von Kalle, Thekl ...
-
Scheer, Monika
-
visa fler...
-
Muenter, Marc
-
Bielack, Stefan ...
-
Weclawek-Tompol, ...
-
Ladenstein, Ruth
-
Niggli, Felix
-
Ljungman, Gustaf ...
-
Fuchs, Joerg
-
Hettmer, Simone
-
Koscielniak, Ewa
-
Klingebiel, Thom ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Hematologi
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Pediatrik
- Artiklar i publikationen
-
Pediatric Blood ...
- Av lärosätet
-
Uppsala universitet